Reaction
Injection Site Abscess reporting signals
As of the last recalculation, Injection Site Abscess appears in 2,450 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is NALTREXONE (PRR 73.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Naltrexone | 240 | 73.2 | 73.8 |
| Cabotegravir | 39 | 41.7 | 41.9 |
| Interferon Beta-1B | 79 | 36.1 | 36.3 |
| Methylprednisolone Acetate | 31 | 33.3 | 33.4 |
| Leuprolide Acetate | 182 | 21.5 | 21.5 |
| Medroxyprogesterone Acetate | 84 | 14.8 | 14.8 |
| Paliperidone Palmitate | 49 | 13.2 | 13.2 |
| Lanreotide Acetate | 12 | 13.1 | 13.1 |
| Interferon Beta-1A | 231 | 11.1 | 11.1 |
| Amphetamine | 9 | 9.3 | 9.3 |
| Buprenorphine | 96 | 9.1 | 9.1 |
| Bicalutamide | 16 | 9.0 | 9.0 |
| Insulin Glulisine | 9 | 7.5 | 7.5 |
| Glatiramer Acetate | 43 | 6.2 | 6.2 |
| Testosterone Cypionate | 5 | 4.8 | 4.8 |
| Methadone Hydrochloride | 6 | 4.7 | 4.7 |
| Triamcinolone Acetonide | 17 | 4.7 | 4.7 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 13 | 4.6 | 4.6 |
| Ethyl Alcohol | 11 | 3.5 | 3.5 |
| Isopropyl Alcohol | 13 | 3.3 | 3.3 |
| Pegvaliase-Pqpz | 3 | 3.1 | 3.1 |
| Botulinum Toxin Type A | 4 | 2.7 | 2.7 |
| Treprostinil | 38 | 2.6 | 2.6 |
| Exenatide | 16 | 2.6 | 2.6 |
| Alcohol | 11 | 2.4 | 2.4 |
| Palivizumab | 4 | 2.2 | 2.2 |
| Dulaglutide | 15 | 1.4 | 1.4 |
| Tirzepatide | 17 | 0.9 | 0.9 |